Improved Early Risk Stratification with Cystatin C-based eGFR

Lignende værker

• Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
  af: Grubb, Anders, et al.
  Udgivet: (2012)
• Differences Between Cystatin C and Creatinine-based eGFR—Early Evidence of a Clinical Marker for Frailty
  af: McAdams-DeMarco, Mara, et al.
  Udgivet: (2020)
• Comparison of Serum Cystatin C, Serum Creatinine, Measured GFR, and Estimated GFR to Assess the Risk of Kidney Failure in American Indians With Diabetic Nephropathy
  af: PAVKOV, MEDA E., et al.
  Udgivet: (2013)
• Cystatin C and Creatinine-based eGFR equation performance depends on patient characteristics
  af: Meeusen, Jeffrey W., et al.
  Udgivet: (2015)
• Clinical Assessment of Follow-Up Cystatin C-Based eGFR in Live Kidney Donors
  af: Han, Hyun Ho, et al.
  Udgivet: (2012)